HLA-DPA1, major histocompatibility complex, class II, DP alpha 1, 3113
N. diseases: 139; N. variants: 67
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 6 | 33064411 | downstream gene variant | G/A;T | snv |
|
Digestive System Diseases; Infections | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Digestive System Diseases; Infections | 0.900 | 0.913 | 23 | 2009 | 2019 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Digestive System Diseases; Infections | 0.760 | 1.000 | 8 | 2011 | 2017 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Digestive System Diseases; Neoplasms | 0.740 | 0.600 | 5 | 2011 | 2015 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.050 | 0.600 | 5 | 2011 | 2014 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2007 | 2009 | |||||||
|
1.000 | 0.080 | 6 | 33068100 | 3 prime UTR variant | A/C;G | snv |
|
Digestive System Diseases; Infections | 0.700 | 1.000 | 2 | 2011 | 2013 | ||||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Skin and Connective Tissue Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Infections; Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | < 0.001 | 1 | 2011 | 2011 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.010 | < 0.001 | 1 | 2011 | 2011 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.701 | 0.440 | 6 | 33065245 | 3 prime UTR variant | A/G | snv | 0.29 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 6 | 33068192 | 3 prime UTR variant | A/C;G | snv |
|
Digestive System Diseases; Infections | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.080 | 6 | 33068433 | 3 prime UTR variant | G/T | snv | 0.32 |
|
Digestive System Diseases; Infections | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.080 | 6 | 33068400 | 3 prime UTR variant | A/G | snv | 0.32 |
|
Digestive System Diseases; Infections | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
6 | 33080823 | synonymous variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
0.925 | 0.160 | 6 | 33081144 | non coding transcript exon variant | A/G | snv | 0.27 |
|
Digestive System Diseases; Infections | 0.710 | 1.000 | 2 | 2013 | 2015 | |||||||
|
1.000 | 0.080 | 6 | 33066047 | non coding transcript exon variant | C/T | snv | 0.21 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.120 | 6 | 33067038 | non coding transcript exon variant | G/A | snv | 0.10 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 |